Huijun Xiao

Ms. Huijun Xiao

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

22 August 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
ACArjun Chatterjee
Arjun Chatterjee
ASAmandeep Singh
Amandeep Singh
RTRaj Jessica Thomas
Raj Jessica Thomas
RPRenan Prado
Renan Prado
RKRidhima Kaul
Ridhima Kaul
PCPrabhleen Chahal
Prabhleen Chahal
INTRODUCTION: Fatty pancreas disease (FPD), marked by excess fat within the pancreas, is often incidentally detected on imaging. Despite recognized metabolic links, its clinical significance remains unclear. More granular data from large, well-characterized US cohorts are needed to clarify its relevance. This study quantified intrapancreatic fat deposition and assess its natural history and related outcomes. METHODS: Adults 18 years and older with radiologically confirmed FPD between 2004 and 2024 were identified from institutional databases. Controls without FPD were matched 1:2 by age, sex, body mass index, and smoking status. Patients with excessive alcohol intake, previous pancreatitis, pancreatic cancer, surgery, cystic fibrosis, or prolonged steroid/antiviral use were excluded. Fat content in the pancreas and liver, as well as subcutaneous and visceral fat areas, were measured using iNtuition software on noncontrast computed tomography scans. RESULTS: We included 82 FPD patients and 164 matched controls (median age 65 years; 55% women; median body mass index 32). Subcutaneous and hepatic fat were similar between groups, but intrapancreatic fat deposition was markedly higher in FPD patients (26.8% vs 4.9%, P < 0.001). Over a mean 4-year follow-up, FPD patients had significantly higher rates of acute pancreatitis (12% vs 1.2%, P < 0.001), chronic pancreatitis (6.1% vs 0.6%, P = 0.017), pancreatic cysts (34.1% vs 4.9%, P < 0.001), and pancreatic cancer (1.6% vs 0%, P = 0.012). Extrapancreatic cancer incidence did not differ. DISCUSSION: FPD is associated with an increased risk of pancreatic cancer, acute pancreatitis, chronic pancreatitis, and incidental pancreatic cysts, independent of obesity or hepatic steatosis, suggesting a potentially causative role of FPD in the pathogenesis of exocrine pancreatic diseases.

JNJiafei Niu
Jiafei Niu
WAWael A. Al-Yaman
Wael A. Al-Yaman
KPKanokwan Pinyopornpanish
Kanokwan Pinyopornpanish
JPJi Seok Park
Ji Seok Park
MSMiguel Salazar
Miguel Salazar
JWJamile′ Wakim-Fleming
Jamile′ Wakim-Fleming
This multi-center retrospective study examined the effect of weight loss on the prevention of progression to cirrhosis in a sample exclusively composed of patients with obesity and MASH-related F3 liver fibrosis. Adult patients with obesity and biopsy-confirmed MASH-related F3 liver fibrosis (n = 101) from two liver transplant centers in the US were included in the study. A higher proportion of patients who did not progress to cirrhosis achieved >5% weight loss at follow-up (59% vs. 30%, p = 0.045). In multivariable analysis, patients with >5% weight loss at follow-up had a lower hazard of developing cirrhosis compared to patients with no weight loss or weight gain (HR: 0.29, 95%, CI: 0.08–0.96); whereas, diabetes (HR: 3.24, 95%, CI: 1.21–8.67) and higher LDL levels (HR: 1.02, 95%, CI: 1.01–1.04) were associated with higher hazards of progression to cirrhosis. Weight loss >5% has the potential to prevent disease progression to cirrhosis in patients with obesity and MASH-related F3 liver fibrosis. The realization of this benefit requires weight loss maintenance longer than one year. Larger prospective studies are needed to determine how weight loss impacts other patient-centered outcomes such as mortality, hepatic decompensation, and hepatocellular carcinoma in patients with obesity and MASH-related F3 liver fibrosis.

5 August 2025 in Histopathology
Verified
Journal Article
Open access
CDChien‐Kuang C Ding
Chien‐Kuang C Ding
HXHuijun Xiao
Huijun Xiao
JNJane K Nguyen
Jane K Nguyen
CPChristopher G Przybycin
Christopher G Przybycin
RAReza Alaghehbandan
Reza Alaghehbandan
JMJesse K. McKenney
Jesse K. McKenney
Aims: A dichotomous classifier for prostatic adenocarcinoma, favourable and unfavourable histology, was recently proposed to optimize metastasis prediction. We evaluate interobserver agreement for its classification.Methods and results: Fifty biopsies with prostatic adenocarcinoma were selected. One slide per biopsy was scanned using the Aperio AT2 scanner (20x) and viewed in Leica Web Viewer. Ten pathologists reviewed each slide after completing a training module. Biopsies were scored for Grade Group (1–5) and presence of unfavourable histology. Forty‐one of 50 biopsies (82%) had unanimous consensus [13 (32%) unfavourable and 28 (68%) favourable], 47 (94%) for at least 9 of 10 reviewers, and 48 (96%) for at least 8 of 10 reviewers. Percent agreement for favourable/unfavourable classification was 94%, kappa = 0.88 (95% CI: 0.8, 0.96), and Gwet's AC1 coefficient = 0.90 (95% CI: 0.82, 0.97) [both P‐value < 0.001]. Inter‐rater agreement for Grade Group designation was evaluated in biopsies with 100% consensus. In the favourable consensus group (n = 28), kappa for Grade Group was 0.80 (95% CI: 0.62, 0.98) and Kendall's W was 0.83 (95% CI: 0.81, 0.89), with both P‐value < 0.001. For the unfavourable consensus group (n = 13), kappa for Grade Group was 0.56 (95% CI: 0.36, 0.75) and Kendall's W was 0.78 (95% CI: 0.76, 0.85), with both P‐value < 0.001.Conclusions: The classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement, even when learnt through a simple tutorial. GG designation was more variable. This provides evidence that the favourable/unfavourable classification could be utilized in routine practice given its ease of use.

17 February 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
MSMatthew T. Siuba
Matthew T. Siuba
JLJames Lane
James Lane
VMVaidehi Mendpara
Vaidehi Mendpara
DTDavid Toth
David Toth
DPDeborah Paul
Deborah Paul
ATAdriano R. Tonelli
Adriano R. Tonelli
Background: Accurate cardiac output (CO) measurements during exercise are essential for the diagnosis of exercise pulmonary hypertension (PH), exercise precapillary PH, and exercise postcapillary PH. The purpose of this study is to compare performance of thermodilution CO to gold‐standard direct Fick CO (dfCO) at rest and exercise. Methods: A single‐center prospective cohort study of patients undergoing invasive cardiopulmonary exercise test over a 3‐year period. For the primary outcome, we predicted CO at each stage of exercise and recovery using generalized additive modeling. In secondary analysis, we assessed mean differences in CO across exercise stages and Bland–Altman analysis at rest and peak exercise. Finally, we assessed the impact in classification of exercise PH, exercise precapillary PH, and exercise postcapillary PH between the 2 CO methods. Results: A total of 302 patients were included. In the primary analysis, the generalized additive model smooth term was significantly different between thermodilution and dfCO ( P <0.001), with thermodilution underestimating dfCO at rest and overestimating dfCO at max exercise. Wide limits of agreement were noted between thermodilution and dfCO, particularly at peak exercise (−0.08 (−4.5 to +4.35) L/min). The classification of exercise PH, exercise precapillary PH, and exercise postcapillary PH was not significantly different between CO methods (4, 3, and 1 patient misclassified by thermodilution, respectively). CO reserve using thermodilution was overestimated compared with dfCO (96.66% versus 88.45%, P <0.001). Conclusions: There are differences and wide limits of agreement between thermodilution and dfCO both at rest and during exercise. Sequential measurement of thermodilution during exercise with computing of mPAP/CO and PAWP/CO slopes, reduced the clinical impact of the differences in the diagnosis of exercise PH or exercise postcapillary PH.

29 December 2025 in Critical Care Explorations
Verified
Journal Article
Open access
NMNasim Motayar
Nasim Motayar
Krzysztof LaudanskiKrzysztof Laudanski
Krzysztof Laudanski
HXHuijun Xiao
Huijun Xiao
XWXiaofeng F. Wang
Xiaofeng F. Wang
HHHesham A. Hassaballa
Hesham A. Hassaballa
AHAndre L Holder
Andre L Holder
OBJECTIVES: Current research does not address the existence and impact of structured tele-critical care (TCC) training on the delivery of care in the ICU. This pilot study aimed to evaluate the association between on boarding elements focused on training and clinicians perceptions of delivery of care. DESIGN: Cross-sectional survey study. SETTING AND PARTICIPANTS: Critical Care professionals at four U.S. hospitals, professional meetings and Society of Critical Care Medicine’s International Membership base. Participants were active clinicians who practice in the TCC setting. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 432 participants responded to the survey, 227 met the eligibility criteria (52.5%) and were included in the analysis. Respondents were a multi-professional group of TCC clinicians aged between 35–55 years of age (56.4%). Seventy-four percent of respondents reported having orientation before providing TCC, 46% reported having formal mentorship, and 66% reported formal training on their institutional platform. Provision of orientation before participating in a TCC program was associated with higher ratings of feeling prepared (odds ratio [OR], 3.52; p < 0.001) and feeling accepted as part of the ICU team (OR, 2.21; p = 0.008). Mentorship was associated with feeling more prepared (OR, 8.2; p < 0.001) and higher comfort in delivering care (OR, 2.78; p = 0.016). Platform training was associated with feeling more prepared (OR, 4.66; p < 0.001), comfortable in delivering care (OR, 3.6; p = 0.002), feeling accepted as part of the team (OR, 3.18; p < 0.001), and more likely to participate in quality improvement (OR, 2.51; p = 0.001). A site visit also made a positive impact in feeling prepared (OR, 2.86; p < 0.001), comfortable (OR, 4.95; p = 0.002), feeling like recommendations were accepted (OR, 3.73; p < 0.001), more likely to recommend TCC (OR, 3.18; p = 0.001), and participating in quality improvement (OR, 3.24; p < 0.001). CONCLUSIONS: In this pilot study, structured training utilizing orientation, mentorship, and platform training as surrogates, along with a site visit before beginning delivery of care in a TCC setting, were associated with more positive perceptions in the delivery of care domains assessed. We highlight potentially important factors that warrant further evaluation and assessment of the need for standardization across TCC programs.